Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa

Journal of Gastroenterology and Hepatology (Australia)

Volumn 19, Issue 6, 2004, Pages 676-682

  Herath, Nirmitha I ^a,d   Walsh, Michael D ^a   Kew, Michael C ^c   Young, Joanne ^a   Leggett, Barbara A ^a   Macdonald, Graeme A ^b  

^a Royal Brisbane and Womens Hospital Research Foundation   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Chromosomal instability; Hepatocellular carcinoma; Methylation

Indexed keywords

CADHERIN; CATENIN;

ADULT; AGED; ARTICLE; AUSTRALIA; CHROMOSOME MUTATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GEOGRAPHY; HETEROZYGOSITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CELL CARCINOMA; MALE; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SOUTH AFRICA;

EID: 3042819723     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2004.03361.x     Document Type: Article

References (27)

1. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT. NIH conference. Hepatocellular carcinoma. Ann. Intern. Med. 1988; 108: 390-401.
2. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of twenty-five major cancers. Int. J. Cancer 1999; 80: 827-41.
3. Kraus C, Liehr T, Hulsken J et al. Localization of the human beta-catenin gene (CTNNB1) to 3p21: a region implicated in tumor development. Genomics 1994; 23: 272-4.
4. Lara-Pezzi E, Roche S, Andrisani OM, Sanchez-Madrid F, Lopez-Cabrera M. The hepatitis B virus HBx protein induces adherens junction disruption in a src-dependent manner. Oncogene 2001; 20: 3323-31.
5. Kanai Y, Ushijima S, Tsuda H, Sakamoto M, Sugimura T, Hirohashi S. Aberrant DNA methylation on chromosome 16 is an early event in hepatocarcinogenesis. Jpn. J. Cancer Res. 1996; 87: 1210-17.
6. Slagle BL, Zhou YZ, Birchmeier W, Scorsone KA. Deletion of the E-cadherin gene in hepatitis B virus-positive Chinese hepatocellular carcinomas. Hepatology 1993; 18: 757-62.
7. Balsara BR, Pei J, De Rienzo A et al. Human hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1-24.1. Genes Chromosomes Cancer 2001; 30: 245-53.
8. Guilford P, Hopkins J, Harraway J et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392: 402-5.
9. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res. 1998; 58: 1130-4.
10. de La Coste A, Romagnolo B, Billuart P et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl Acad. Sci. USA 1998; 95: 8847-51.
11. Satoh S, Daigo Y, Furukawa Y et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat. Genet. 2000; 24: 245-50.
12. Legoix P, Bluteau O, Bayer J et al. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity. Oncogene 1999; 18: 4044-6.
13. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 1996; 272: 1023-6.
14. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16: 1215.
15. Tamura G, Yin J, Wang S et al. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J. Natl Cancer Inst. 2000; 92: 569-73.
16. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA 1996; 93: 9821-6.
17. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem. 1991; 39: 741-8.
18. Kew MC. Clinical, pathologic, and etiologic heterogeneity in hepatocellular carcinoma: evidence from southern Africa. Hepatology 1981; 1: 366-9.
19. Tokino T, Tamura H, Hori N, Matsubara K. Chromosome deletions associated with hepatitis B virus integration. Virology 1991; 185: 879-82.
20. Kanai Y, Ushijima S, Hui AM et al. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int. J. Cancer 1997; 71: 355-9.
21. Graff JR, Herman JG, Lapidus RG et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 1995; 55: 5195-9.
22. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl Acad. Sci. USA 1995; 92: 7416-19.
23. Matsumura T, Makino R, Mitamura K. Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas. Clin. Cancer Res. 2001; 7: 594-9.
24. Wei Y, Nhieu J, Prigent S, Srivatanakul P, Tiollais P, Buendia M. Altered expression of E-cadherin in hepatocellular carcinoma: Correlations with genetic alterations, β-catenin expression, and clinical features. Hepatology 2002; 36: 692-701.
25. Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991; 350: 429-31.
26. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991; 350: 427-8.
27. Herath NI, Kew MC, Walsh MD et al. Reciprocal relationship between methylation status and loss of heterozygosity at the p14ARF locus in Australian and South African hepatocellular carcinomas. J. Gastroenterol. Hepatol. 2002; 17: 301-7.